Fundraising FoxEpisteme Prognostics, Inc.
Brooklyn, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into Episteme Prognostics, Inc.
Sign up to see every warm intro you have to Episteme Prognostics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Episteme Prognostics, Inc. team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SD
Surajit DharaNamed on SEC filing
Board
JR
Jason RifkinBoard director
GP
RW
Robert WarrenBoard director
Investors · 1
WHINinferredNew York
How we know: board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$9.8M disclosed across 4 rounds · 2021–2026
▶$5.1MraisedSep 2026 · 14 investors · BiotechnologyRule 506(b)
▶$5.1MraisedSep 2026 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Surajit DharaExecutive Officer, Director
- Gregory HoDirector
- Jason RifkinDirector
- Offering amount
- $6M
- Amount sold
- $5.1M
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$550KraisedMar 2025 · 1 investors · BiotechnologyRule 506(b)
▶$550KraisedMar 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason RifkinDirector
- Surajit DharaExecutive Officer, Director
- Gregory P. HoDirector
- Robert WarrenDirector
- Offering amount
- $2.5M
- Amount sold
- $550K
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$4.1MraisedMay 2023 · 16 investors · BiotechnologyRule 506(b)
▶$4.1MraisedMay 2023 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Surajit DharaExecutive Officer, Director
- Robert WarrenDirector
- Gregory HoDirector
- Jason RifkinDirector
- Offering amount
- $4.1M
- Amount sold
- $4.1M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$80KraisedJan 2022 · 5 investors · BiotechnologyRule 506(b)
▶$80KraisedJan 2022 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Surajit DharaExecutive Officer, Director
- Marek Herrmann-NowosielskiExecutive Officer
- Offering amount
- $3M
- Amount sold
- $80K
- Proceeds to insiders
- $75K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Episteme Prognostics, Inc.'s investors?
- Episteme Prognostics, Inc.'s investors include WHIN.
- How much funding has Episteme Prognostics, Inc. raised?
- Episteme Prognostics, Inc. has disclosed $9.8M raised across 4 rounds.
- Where is Episteme Prognostics, Inc. headquartered?
- Episteme Prognostics, Inc. is headquartered in Brooklyn, US.